V-Akt Murine Thymoma Viral Oncogene Homolog 1 抗体
(V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1))
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| AKT1 抗体 (pSer124) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (Ser131) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (C-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pSer129) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pThr72) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pTyr326) | 人 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (Ser124) | 人 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (Tyr434, Tyr437) | 人 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pThr450) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pThr72) | 人 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pSer124) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant AKT1 抗体 (pThr450) | 人 | 兔 Monoclonal |
|
|
|
| AKT1 抗体 (pSer473) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| AKT1 抗体 (AA 381-480) | 人 | 小鼠 Polyclonal |
|
|
|
| AKT1 抗体 (AA 107-135) | 人 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pThr450) | 人 | 兔 Polyclonal |
|
|
|
| AKT1 抗体 (pSer129) | 人 | 兔 Monoclonal |
|
|
|
| AKT1 抗体 (Internal Region) | 人 | 山羊 Polyclonal |
|
|
|
| AKT1 抗体 (Internal Region) | 人, 小鼠 | 山羊 Polyclonal |
|
|
|
| AKT1 抗体 (AA 292-341) | 人, 小鼠, 大鼠, 猴 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer124
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Ser131
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer129
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr72
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pTyr326
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Ser124
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Tyr434, Tyr437
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr450
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr72
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer124
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 2A4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
- 抗原表位
- pThr450
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 381-480
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB25385
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 107-135
Primary Antibody
- DB (Dot Blot: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB29255
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- pThr450
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer129
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人, 小鼠
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 292-341
Latest Publications for our V-Akt Murine Thymoma Viral Oncogene Homolog 1 抗体
: "Enforced expression of miR-92b blunts E. coli lipopolysaccharide-mediated inflammatory injury by activating the PI3K/AKT/β-catenin pathway via targeting PTEN." in: International journal of biological sciences, Vol. 17, Issue 5, pp. 1289-1301, (2022) (PubMed).
: "ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer." in: Aging, Vol. 12, Issue 10, pp. 9915-9934, (2021) (PubMed).
: "SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway." in: Frontiers in oncology, Vol. 11, pp. 638701, (2021) (PubMed).
: "Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway." in: Frontiers in pharmacology, Vol. 12, pp. 670054, (2021) (PubMed).
: "8-Gingerol Ameliorates Myocardial Fibrosis by Attenuating Reactive Oxygen Species, Apoptosis, and Autophagy via the PI3K/Akt/mTOR Signaling Pathway." in: Frontiers in pharmacology, Vol. 12, pp. 711701, (2021) (PubMed).
: "The neuronal receptor tyrosine kinase Alk is a target for longevity." in: Aging cell, Vol. 19, Issue 5, pp. e13137, (2020) (PubMed).
: "PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism." in: BMC molecular biology, Vol. 20, Issue 1, pp. 24, (2020) (PubMed).
: "Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression." in: Bioscience reports, Vol. 39, Issue 6, (2020) (PubMed).
: "Woodchuck VEGF (wVEGF) characteristics: Model for angiogenesis and human hepatocellular carcinoma directed therapies." in: Archives of biochemistry and biophysics, Vol. 661, pp. 97-106, (2019) (PubMed).
: "A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer." in: Pharmacological research, Vol. 129, pp. 500-514, (2019) (PubMed).
: "ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer." in: Aging, Vol. 12, Issue 10, pp. 9915-9934, (2021) (PubMed).
: "SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway." in: Frontiers in oncology, Vol. 11, pp. 638701, (2021) (PubMed).
: "Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway." in: Frontiers in pharmacology, Vol. 12, pp. 670054, (2021) (PubMed).
: "8-Gingerol Ameliorates Myocardial Fibrosis by Attenuating Reactive Oxygen Species, Apoptosis, and Autophagy via the PI3K/Akt/mTOR Signaling Pathway." in: Frontiers in pharmacology, Vol. 12, pp. 711701, (2021) (PubMed).
: "The neuronal receptor tyrosine kinase Alk is a target for longevity." in: Aging cell, Vol. 19, Issue 5, pp. e13137, (2020) (PubMed).
: "PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism." in: BMC molecular biology, Vol. 20, Issue 1, pp. 24, (2020) (PubMed).
: "Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression." in: Bioscience reports, Vol. 39, Issue 6, (2020) (PubMed).
: "Woodchuck VEGF (wVEGF) characteristics: Model for angiogenesis and human hepatocellular carcinoma directed therapies." in: Archives of biochemistry and biophysics, Vol. 661, pp. 97-106, (2019) (PubMed).
: "A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer." in: Pharmacological research, Vol. 129, pp. 500-514, (2019) (PubMed).
Aliases for V-Akt Murine Thymoma Viral Oncogene Homolog 1 抗体
AKT serine/threonine kinase 1 (AKT1) 抗体thymoma viral proto-oncogene 1 (Akt1) 抗体
protein tyrosine kinase 2 beta (PTK2B) 抗体
CG4006 gene product from transcript CG4006-RE (Akt1) 抗体
actin beta (ACTB) 抗体
AKT serine/threonine kinase 1 (Akt1) 抗体
v-akt murine thymoma viral oncogene homolog 1 S homeolog (akt1.S) 抗体
v-akt murine thymoma viral oncogene homolog 1 (akt1) 抗体
AKT serine/threonine kinase 1 (akt1) 抗体
K+ transporter 1 (KT1) 抗体
Serine/threonine-protein kinase akt-1 (akt-1) 抗体
ACT-5 抗体
AKT 抗体
Akt 抗体
akt 抗体
akt-1 抗体
AKT/PKB 抗体
Akt/PKB 抗体
AKT1 抗体
Akt1 抗体
akt1 抗体
ATAKT1 抗体
CADTK 抗体
CAKB 抗体
CG4006 抗体
CWS6 抗体
D-Akt 抗体
DAkt 抗体
Dakt 抗体
dAKT 抗体
dAkt 抗体
dakt 抗体
dAKT/dPKB 抗体
dAkt/PKB 抗体
DAKT1 抗体
DAkt1 抗体
Dakt1 抗体
dAKT1 抗体
dAkt1 抗体
dakt1 抗体
DAKT1/PKB 抗体
Dmel\\CG4006 抗体
DPKB 抗体
Dpkb 抗体
dPKB 抗体
DRAC-PK 抗体
DRAC-PK66 抗体
DRAC-PK85 抗体
F18A8.2 抗体
F18A8_2 抗体
FADK2 抗体
FAK2 抗体
K+ transporter 1 抗体
l(3)04226 抗体
l(3)89Bq 抗体
p-Akt 抗体
pAkt 抗体
PKB 抗体
pkb 抗体
PKB-ALPHA 抗体
PKB/Akt 抗体
PKB/AKT 抗体
PKB/dAKT 抗体
PKBalpha 抗体
POTASSIUM TRANSPORTER 抗体
PRKBA 抗体
PTK 抗体
PYK2 抗体
RAC 抗体
Rac 抗体
RAC-ALPHA 抗体
RacPK 抗体
RAFTK 抗体
v-akt 抗体
v-akt1 抗体
xAct 抗体
您还需要查找其他产品吗？
- UXT 抗体
- UXS1 抗体
- UVSSA/KIAA1530 抗体
- UVRAG 抗体
- Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats 抗体
- UTY 抗体
- UTS2R 抗体
- Utrophin 抗体
- UTP6 抗体
- UTP3 抗体
- UTP25/DIEXF 抗体
- UTP23 抗体
- UTP20 抗体
- UTP18 抗体
- UTP15 抗体
- UTP14C 抗体
- UTP14A 抗体
- UTP11L 抗体
- UTF1 抗体
- UST 抗体
- V-Ets erythroblastosis Virus E26 Oncogene Homolog 1 (Avian) 抗体
- V-Ral Simian Leukemia Viral Oncogene Homolog B (Ras Related, GTP Binding Protein) 抗体
- V-type immunoglobulin domain-containing suppressor of T-cell activation 抗体
- VAC14 抗体
- Vacuolar Protein Sorting 35 抗体
- Vacuolar Protein Sorting-Associated Protein 26A 抗体
- Valosin Containing Protein 抗体
- Valyl-tRNA Synthetase 2, Mitochondrial 抗体
- VAMP2 抗体
- VAMP3 抗体
- VAMP4 抗体
- VAMP5 抗体
- VAMP7 抗体
- VAMP8 抗体
- Vang-Like 2 抗体
- Vangl1 抗体
- VAPA 抗体
- VAPB 抗体
- Variable Charge, Y-Linked 抗体
- VARS 抗体
You are here:
